Precision BioSciences, Inc.
DTIL
$4.62
-$0.13-2.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.89% | -8.04% | -150.15% | 281.33% | 152.72% |
| Total Depreciation and Amortization | -6.87% | -25.12% | -26.85% | -3.15% | -8.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 181.01% | -553.90% | 91.24% | 47.73% | -358.33% |
| Change in Net Operating Assets | -243.73% | -90.90% | 122.26% | -118.75% | -787.95% |
| Cash from Operations | -1.98% | -216.02% | 60.24% | 21.66% | -125.35% |
| Capital Expenditure | 34.02% | -148.72% | -39.29% | 67.44% | -430.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | 62.16% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Investing | -223.71% | -51.56% | -128.57% | -7.69% | -161.90% |
| Total Debt Issued | -- | -100.09% | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | 79.92% | 58.40% | 434.19% | -98.25% | 1,317.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 80.52% | 58.59% | 431.77% | -98.25% | 1,317.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.51% | -473.34% | 84.20% | -167.31% | 479.76% |